• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19.

作者信息

Hirsch Jamie S, Uppal Nupur N, Sharma Purva, Khanin Yuriy, Shah Hitesh H, Malieckal Deepa A, Bellucci Alessandro, Sachdeva Mala, Rondon-Berrios Helbert, Jhaveri Kenar D, Fishbane Steven, Ng Jia H

机构信息

Department of Medicine, Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, NY, USA.

Institute of Health Innovations and Outcomes Research, Feinstein Institutes for Medical Research, Manhasset, NY, USA.

出版信息

Nephrol Dial Transplant. 2021 May 27;36(6):1135-1138. doi: 10.1093/ndt/gfab067.

DOI:10.1093/ndt/gfab067
PMID:33724428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7989196/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4043/8160942/45df575154bf/gfab067f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4043/8160942/6b6d4725e492/gfab067f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4043/8160942/45df575154bf/gfab067f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4043/8160942/6b6d4725e492/gfab067f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4043/8160942/45df575154bf/gfab067f2.jpg

相似文献

1
Prevalence and outcomes of hyponatremia and hypernatremia in patients hospitalized with COVID-19.新型冠状病毒肺炎住院患者低钠血症和高钠血症的患病率及转归
Nephrol Dial Transplant. 2021 May 27;36(6):1135-1138. doi: 10.1093/ndt/gfab067.
2
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis.低钠血症和高钠血症对 COVID-19 肺炎的预后影响。HOPE-COVID-19（COVID-19 的健康结局预测评估）登记分析。
Front Endocrinol (Lausanne). 2020 Nov 30;11:599255. doi: 10.3389/fendo.2020.599255. eCollection 2020.
3
Associations of Dysnatremia with COVID-19 Status and Mortality.血清钠紊乱与 COVID-19 状态和死亡率的关系。
Kidney360. 2022 Jun 3;3(8):1323-1331. doi: 10.34067/KID.0001062022. eCollection 2022 Aug 25.
4
Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19.低钠血症是新冠病毒肺炎住院患者发病和死亡的一个预测指标。
J Clin Endocrinol Metab. 2021 May 13;106(6):1637-1648. doi: 10.1210/clinem/dgab107.
5
Dysnatremia is an Independent Indicator of Mortality in Hospitalized Patients.低钠血症是住院患者死亡的独立指标。
Med Sci Monit. 2017 May 21;23:2408-2425. doi: 10.12659/msm.902032.
6
Burden of sodium abnormalities in patients hospitalized for heart failure.因心力衰竭住院患者的钠异常负担
Congest Heart Fail. 2011 Jan-Feb;17(1):1-7. doi: 10.1111/j.1751-7133.2010.00206.x. Epub 2011 Jan 24.
7
Hyponatremia prolongs hospital stay and hypernatremia better predicts mortality than hyponatremia in hospitalized patients with community-acquired pneumonia.低钠血症会延长社区获得性肺炎住院患者的住院时间，且高钠血症比低钠血症更能预测此类患者的死亡率。
Tuberk Toraks. 2019 Dec;67(4):239-247. doi: 10.5578/tt.68779.
8
Sodium levels on admission are associated with mortality risk in hospitalized patients.入院时的钠水平与住院患者的死亡风险相关。
Eur J Intern Med. 2017 Dec;46:25-29. doi: 10.1016/j.ejim.2017.07.017. Epub 2017 Jul 8.
9
Efficacy and safety of isotonic versus hypotonic intravenous maintenance fluids in hospitalized children: an updated systematic review and meta-analysis of randomized controlled trials.等渗与低渗静脉维持液在住院儿童中的疗效和安全性：一项更新的系统评价和随机对照试验荟萃分析。
Pediatr Nephrol. 2024 Jan;39(1):57-84. doi: 10.1007/s00467-023-06032-7. Epub 2023 Jun 26.
10
Effect of Electrolyte Imbalance on Mortality and Late Acute Kidney Injury in Hospitalized COVID-19 Patients.电解质失衡对住院 COVID-19 患者死亡率和晚期急性肾损伤的影响。
Iran J Kidney Dis. 2022 Jul;16(4):228-237.

引用本文的文献

1
Hyponatremia and the risk of sepsis in the setting of chronic kidney disease not on dialysis.慢性肾脏病未透析患者的低钠血症与脓毒症风险
Clin Kidney J. 2025 Jun 4;18(6):sfaf133. doi: 10.1093/ckj/sfaf133. eCollection 2025 Jun.
2
Severe hyponatremia in a mild COVID-19 patient: diagnostic challenges of SIADH and adrenal insufficiency.一名轻症新型冠状病毒肺炎患者的严重低钠血症：抗利尿激素分泌异常综合征和肾上腺功能不全的诊断挑战
CEN Case Rep. 2025 May 2. doi: 10.1007/s13730-025-00995-2.
3
ICU-acquired hypernatremia: Prevalence, patient characteristics, trajectory, risk factors, and outcomes.

本文引用的文献

1
Electrolyte abnormalities in patients hospitalized with COVID-19.新冠病毒疾病住院患者的电解质异常情况。
Clin Kidney J. 2021 Mar 16;14(6):1704-1707. doi: 10.1093/ckj/sfab060. eCollection 2021 Jun.
2
Hypernatremia-A Manifestation of COVID-19: A Case Series.高钠血症——新型冠状病毒肺炎的一种表现：病例系列
A A Pract. 2020 Jul;14(9):e01295. doi: 10.1213/XAA.0000000000001295.
3
Prevalence and Impact of Hyponatremia in Patients With Coronavirus Disease 2019 in New York City.纽约市 2019 冠状病毒病患者低钠血症的患病率和影响。
重症监护病房获得性高钠血症：患病率、患者特征、病程、危险因素及结局
Crit Care Resusc. 2024 Nov 22;26(4):303-310. doi: 10.1016/j.ccrj.2024.09.003. eCollection 2024 Dec.
4
A Study of Hydroelectrolytic and Acid-Base Disturbances in MIS-C Patients: A Perspective on Antidiuretic Hormone Secretion.儿童多系统炎症综合征患者水电解质及酸碱平衡紊乱的研究：抗利尿激素分泌视角
Curr Issues Mol Biol. 2024 Oct 16;46(10):11438-11459. doi: 10.3390/cimb46100681.
5
Impact of Hyponatremia on COVID-19-Related Outcomes: A Retrospective Analysis.低钠血症对新型冠状病毒肺炎相关结局的影响：一项回顾性分析
Biomedicines. 2024 Sep 2;12(9):1997. doi: 10.3390/biomedicines12091997.
6
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19.新型冠状病毒肺炎相关抗利尿激素分泌失调综合征/低钠血症
Pituitary. 2024 Dec;27(6):889-897. doi: 10.1007/s11102-024-01446-4. Epub 2024 Aug 28.
7
CT semi-quantitative score used as risk factor for hyponatremia in patients with COVID-19: a cross-sectional study.CT 半定量评分可作为 COVID-19 患者低钠血症的危险因素：一项横断面研究。
Front Endocrinol (Lausanne). 2024 Jun 14;15:1342204. doi: 10.3389/fendo.2024.1342204. eCollection 2024.
8
Editorial: Dysnatremias and related disorders.社论：钠代谢紊乱及相关疾病
Front Med (Lausanne). 2024 Jun 11;11:1411974. doi: 10.3389/fmed.2024.1411974. eCollection 2024.
9
The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review.长新冠综合征发病机制中垂体影响的研究进展：综述。
Adv Respir Med. 2024 Feb 14;92(1):96-109. doi: 10.3390/arm92010013.
10
Association of hypernatremia with mortality in patients with COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎患者高钠血症与死亡率的关联：一项系统评价和荟萃分析。
Immun Inflamm Dis. 2023 Dec;11(12):e1109. doi: 10.1002/iid3.1109.
Crit Care Med. 2020 Dec;48(12):e1211-e1217. doi: 10.1097/CCM.0000000000004605.
4
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US.与美国 2019 年冠状病毒病危重症患者死亡相关的因素。
JAMA Intern Med. 2020 Nov 1;180(11):1436-1447. doi: 10.1001/jamainternmed.2020.3596.
5
Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19.抗利尿激素分泌异常综合征背景下的急性症状性低钠血症作为新型冠状病毒肺炎的一种孤立表现
IDCases. 2020 Jun 1;21:e00859. doi: 10.1016/j.idcr.2020.e00859. eCollection 2020.
6
An unusual case of severe acute hyponatremia in patient with COVID-19 infection.一名新型冠状病毒肺炎（COVID-19）感染患者出现严重急性低钠血症的罕见病例。
Nefrologia (Engl Ed). 2020 May-Jun;40(3):356-358. doi: 10.1016/j.nefro.2020.05.001. Epub 2020 May 8.
7
Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19).严重新型冠状病毒病（COVID-19）患者的电解质失衡。
Ann Clin Biochem. 2020 May;57(3):262-265. doi: 10.1177/0004563220922255. Epub 2020 May 3.
8
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
9
Prevalence, risk factors and prognosis of hypernatraemia during hospitalisation in internal medicine.内科住院期间高钠血症的患病率、危险因素及预后
Neth J Med. 2015 Dec;73(10):448-54.
10
Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.慢性肾脏病伴或不伴充血性心力衰竭患者的低钠血症、高钠血症和死亡率。
Circulation. 2012 Feb 7;125(5):677-84. doi: 10.1161/CIRCULATIONAHA.111.065391. Epub 2012 Jan 5.